Protalix Biotherapeutics Inc (PLX)
CapEx to Revenue
2.98%
Quarterly · Period ending:
PLX CapEx to Revenue
Latest reported2.98%period ending
Latest reported2.98%period ending
PLX Quarterly CapEx/Revenue (0.00% → 2.98%)
Latest values, visible window
High-resolution chart · PNG
PLX capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 2.9805% | |
| 2.2548% | |
| 4.4179% | |
| 2.7898% | |
| 2.7526% | |
| 3.0258% | |
| 2.3329% | |
| 0.4844% | |
| 1.2765% | |
| 15.9552% | |
| 2.3841% | |
| 4.3209% | |
| 0.5816% | |
| 2.5866% | |
| 2.4719% | |
| 0.4089% | |
| 1.4624% | |
| 1.4237% | |
| 5.2404% | |
| 2.8538% | |
| 4.3722% | |
| 3.4099% | |
| 1.4106% | |
| 0.9453% | |
| 1.9331% | |
| 0.3049% | |
| 0.1577% | |
| 2.7513% | |
| 0.3021% | |
| 1.6285% | |
| 0.6958% | |
| 0.8431% | |
| 2.9971% | |
| 5.4689% | |
| 11.7456% | |
| 1.8336% | |
| 5.0802% | |
| 7.6151% | |
| 5.6223% | |
| 3.3619% | |
| 18.3154% | |
| 36.9661% | |
| -0.0357% | |
| 2.1895% | |
| 17.4401% | |
| 5.8511% | |
| 12.1387% | |
| 6.6361% | |
| 4.0208% | |
| 3.5622% | |
| 19.7861% | |
| 9.735% | |
| 22.8133% | |
| 16.1794% | |
| 522.9167% | |
| 14.2857% | |
| 0.9383% | |
| 21.7275% | |
| 29.8052% | |
| 87.0141% | |
| 184.8168% | |
| 43.4% | |
| 88.3503% | |
| 42.1796% | |
| 220.1578% | |
| 259.5092% | |
| 140.9794% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 561.3333% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |